Longevity PapersAbout
← All papers
RESEARCH PAPER / 2026-09-25

Turnera diffusa polysaccharides promote healthy aging through conserved stress response regulation and metabolic remodeling across multiple aging models.

Hailing Wang, Rui Wu, Xuemei Zhang, Xin Meng

School of Pharmacy, Heilongjiang University of Chinese Medicine, No.24 Heping Road, Harbin, 150040, P. R. China. · pubmed

Abstract

Aging is a progressive decline in physiological functions and the capacity to maintain homeostasis, representing a major risk factor for numerous chronic diseases. Geroprotectors, defined as natural or synthetic compounds capable of improving healthspan and delaying age-associated functional decline, have attracted increasing attention in aging research. However, clinically validated interventions for promoting healthy aging remain unavailable. Plant-derived polysaccharides, owing to their excellent safety profiles and diverse biological activities, have emerged as promising candidates for geroprotection. Turnera diffusa Willd. Ex Schult. (T. diffusa) has been reported to exhibit neuroprotective and reproductive system modulating properties; however, the geroprotective potential of its polysaccharides remains unexplored. In the present study, T. diffusa polysaccharides (TDP) were found to significantly extend lifespan and alleviate multiple age-associated physiological declines in both C. elegans and D. melanogaster models. Mechanistic investigations revealed that TDP enhanced the activation of conserved DAF-16/FOXO and HSF-1-mediated stress response pathways, thereby promoting antioxidant defense and maintaining proteostasis. Furthermore,

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

Turnera diffusa polysaccharides extend lifespan in C. elegans and D. melanogaster by activating conserved DAF-16/FOXO and HSF-1 stress response pathways. This is relevant because it investigates a specific geroprotective compound and its mechanism in canonical aging models, although the impact is limited as it relies on well-established pathways (FOXO/HSF-1) and lacks evidence of translational potential or novel mechanistic insights beyond standard geroprotector screening.

Author of this paper? Send a correction.